Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.

The CyberKnife market is experiencing a swift expansion, driven by advancements in medical technology and increasing demand for precise cancer treatments. As healthcare providers and patients seek less invasive options with better outcomes, this sector is set to witness significant growth and innovation. Let’s explore the current market size, key growth drivers, emerging trends, major players, and regional dynamics shaping the future of CyberKnife technology.

CyberKnife Market Size and Growth Projections

The CyberKnife market has seen notable growth in recent years and is projected to continue on this upward trajectory. From a valuation of $0.72 billion in 2025, it is expected to reach $0.84 billion in 2026, demonstrating a strong compound annual growth rate (CAGR) of 16.4%. Historical growth has been supported by factors such as the rising number of cancer cases globally, expansion of radiation oncology facilities, broader acceptance of stereotactic radiosurgery, availability of sophisticated treatment planning software, and advancements in robotic medical technologies.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10562&type=smp

Looking ahead, the market is forecasted to accelerate even further, reaching $1.56 billion by 2030 at a CAGR of 16.6%. This surge will be fueled by increased investment in precision oncology, growing preference for outpatient cancer care, proliferation of advanced cancer treatment centers, integration of artificial intelligence (AI) into radiation therapy planning, and a heightened focus on customizing therapies to individual patient needs. Key trends expected to shape the market include wider adoption of robotic radiosurgery systems, enhanced use of image-guided radiation therapy, rising demand for non-invasive tumor treatments, development of precision radiation platforms, and a stronger emphasis on treatment accuracy and patient safety.

Factors Propelling Growth in the CyberKnife Market

One of the main forces driving the CyberKnife market is the growing preference for non-invasive or minimally invasive medical procedures. These interventions are designed to minimize disruption to normal bodily structures while effectively targeting disease. The CyberKnife robotic radiosurgery system offers notable advantages in this regard, including highly precise tumor targeting, adaptability to tumors that move during treatment, fewer treatment sessions, and enhanced patient comfort.

Access The Complete Cyberknife Market Report:

https://www.thebusinessresearchcompany.com/report/cyberknife-global-market-report

For example, data released in June 2024 by the American Society of Plastic Surgeons showed a 7% increase in minimally invasive procedures in 2023, outpacing the growth of surgical procedures by 2%. Specifically, hand surgeries such as those for carpal tunnel syndrome, arthritis, and trigger finger totaled 207,887 procedures, marking a 2% increase from the previous year. These trends highlight the expanding acceptance and demand for minimally invasive options, which in turn supports the growth of the CyberKnife market.

Breakdown of the CyberKnife Market by Product and Application

This report segments the CyberKnife market into several categories based on system configuration, application, anatomical site, and end user:

– By System Configuration: Fixed CyberKnife Systems, Robotic-Arm CyberKnife Systems, and Upgraded & Refurbished CyberKnife Systems

– By Application: Cancer Treatment, Benign Tumor Treatment, Vascular Malformations, Functional and Other Neurological Disorders

– By Anatomical Site: Brain and Central Nervous System, Spine and Spinal Cord, Lung and Thoracic Region, Prostate and Pelvic Region, Liver and Abdominal Region, Other Anatomical Sites

– By End User: Hospitals, Dedicated Radiotherapy Centers, Cancer Specialty Centers, Academic and Research Institutes

Further subcategories detail system types such as single-room fixed systems, shielded bunker-based systems, multi-axis robotic-arm systems, AI-enabled robotic systems, as well as various software and hardware upgrade options.

Emerging Industry Trends Reshaping the CyberKnife Market

Leading companies in the CyberKnife sector are focusing heavily on innovation, including the development of specialized medical training programs. These initiatives aim to improve the precision of treatments, enhance patient outcomes, and broaden the spectrum of conditions that can be managed with fewer side effects compared to traditional radiation therapies. Medical training programs involve structured education designed to increase healthcare professionals’ expertise in specific technologies and treatment methodologies.

For example, in September 2024, Accuray Incorporated, a US-based manufacturer of radiation therapy systems, launched a dedicated CyberKnife S7 System training facility. This education center provides tailored training and hands-on experience for medical professionals working with CyberKnife and Radixact systems, helping to raise treatment standards and expand clinical capabilities.

Key Players Driving Competition in the CyberKnife Market

The CyberKnife market features several prominent companies competing and innovating in this space. Notable market participants include Accuray Incorporated, Elekta AB, Siemens Healthineers AG, Canon Medical Systems Corporation, Hitachi Ltd., Mitsubishi Electric Corporation, Ion Beam Applications S.A., Mevion Medical Systems Inc., Zap Surgical Systems Inc., ViewRay Inc., RefleXion Medical Inc., Shinva Medical Instrument Co. Ltd., Best Theratronics Ltd., Advanced Oncotherapy PLC, Sumitomo Heavy Industries Ltd., ProTom International Inc., GE HealthCare Technologies Inc., Nordion Inc., Theragenics Corporation, and IsoRay Medical Inc.

Regional Overview and Market Leadership

In 2025, North America accounted for the largest share of the CyberKnife market. Other regions covered in the market report include Asia-Pacific, South East Asia, Western Europe, Eastern Europe, South America, the Middle East, and Africa. While North America currently leads the market, emerging regions are expected to see significant growth in adoption of CyberKnife technologies in the coming years.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model